SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 167 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,152,000 | -10.8% | 36,821 | -28.0% | 0.08% | -12.2% |
| Q4 2016 | $1,291,000 | -2.4% | 51,136 | -4.4% | 0.09% | -7.2% |
| Q3 2016 | $1,323,000 | +29.2% | 53,487 | +6.4% | 0.10% | +26.0% |
| Q2 2016 | $1,024,000 | +30.8% | 50,260 | -2.2% | 0.08% | +40.0% |
| Q1 2016 | $783,000 | -3.1% | 51,365 | -14.6% | 0.06% | +1.9% |
| Q4 2015 | $808,000 | +16.9% | 60,145 | +22.2% | 0.05% | +12.5% |
| Q3 2015 | $691,000 | -48.5% | 49,228 | -55.7% | 0.05% | -41.5% |
| Q1 2015 | $1,342,000 | +47.0% | 111,020 | +0.9% | 0.08% | +54.7% |
| Q4 2014 | $913,000 | – | 109,990 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |